HARP - Harpoon Therapeutics EPS misses by $0.16 misses on revenue May, 06 2020 05:14 PM Harpoon Therapeutics Inc. Harpoon Therapeutics (NASDAQ:HARP): Q1 GAAP EPS of -$0.51 misses by $0.16.More news on: Harpoon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...